Program Director/Principal Investigator (Last, First, Middle): T o t O , R o b e r t D . PROJECT SUMMARY (See instmctions): The CTSA has had a major impact on the clinical and translational research (CTR) environment at UT Southwestern. Many new and highly successful programs in education and training, pilot grant awards, biomedical informatics (BMI), biostatistics, population research, community health sciences, and patient- centered outcomes research have been established. Concurrently, the CTSA stimulated UT Southwestern to invest heavily in CTR infrastructure by recruiting new clinical and translational researchers into leadership positions of major clinical departments, by creating a new research institute that focuses on stem cell biology and cancer and by greatly enhancing genomics, metabolomics, proteomics, bioinformatics, and systems biology. Two new, state-of-the art hospitals are under construction, to open in fall 2014, and they incorporate design elements that will support CTR. Our vision is to accelerate translation of new discoveries into clinical practice (T0-T4) by leveraging our scientific strengths. We will integrate and centralize our resources to work in an encouraging and collaborative research environment. Our three Specific Aims are to: 1) Enhance our Research Environment to Accelerate Translation of Discovery into Practice. We formed the Center for Translational Medicine (Center), directed by the CTSA PI, to serve as the new integrated home for our CTSA. The Center will coordinate and expand the clinical research enterprise while it educates clinical and translational researchers at every level. 2) Leverage Existinq and New Resources to Build on Four Innovative Programs in Translation including: a) Target Identification and Validation; b) Discovery in Humans; c) Intervention in Humans and d) Population Science and Community Engagement. 3) Share Knowledge and Discoverv. and Contribute to the Leadership of the National Consortium. We will share gains that are made in our programs in educational and translational research programs with the Texas Regional CTSA consortium and National CTSA Consortium. We will contribute to leadership in areas of translation including T0-T4 research, and discovery and commercialization of new drugs and devices. Our vision for accelerating CTR is well aligned with the new NCATS initiatives and takes full advantage of gains made in the previous funding. We will establish new and improved programs that will enable investigators to discover, translate and disseminate new knowledge that will improve the prevention, detection, diagnosis, and effective treatment of disease.

Public Health Relevance

Improving the health of our nation requires a concerted effort by medical scientists, health care providers and public health policymakers. This grant application will provide the crucial infrastructure necessary for medical scientists to discover and apply new diagnostics and therapeutics for the detection, prevention, detection, diagnosis and effective treatment of disease. The goal is to accelerate the movement of these new discoveries into clinical practice to improve our nation's health in a safe and effective manner.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001105-03
Application #
8866498
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Talbot, Bernard
Project Start
2013-09-26
Project End
2016-04-30
Budget Start
2015-05-01
Budget End
2016-04-30
Support Year
3
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Kunzler, Elaine; Hynan, Linda S; Chong, Benjamin F (2018) Autoimmune Diseases in Patients With Cutaneous Lupus Erythematosus. JAMA Dermatol 154:712-716
Neeland, Ian J; Singh, Shruti; McGuire, Darren K et al. (2018) Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. Diabetologia 61:2570-2579
Barnes, Arti; Betts, Andrea C; Borton, Eric K et al. (2018) Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS 32:1861-1870
Aboudehen, Karam; Farahani, Shayan; Kanchwala, Mohammed et al. (2018) Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling. J Biol Chem 293:9388-9398
Zhou, Zhengyang; Ku, Hung-Chih; Xing, Guan et al. (2018) Decomposing Pearson's ?2 test: A linear regression and its departure from linearity. Ann Hum Genet 82:318-324
Chen, Yan; Zhang, Bo; Bao, Lei et al. (2018) ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest 128:1937-1955
Thomas-Jardin, Shayna E; Kanchwala, Mohammed S; Jacob, Joan et al. (2018) Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells. Prostate 78:595-606
Thodeson, Drew M; Brulet, Rebecca; Hsieh, Jenny (2018) Neural stem cells and epilepsy: functional roles and disease-in-a-dish models. Cell Tissue Res 371:47-54
Zhang, Honghui; Su, Jianzhong; Wang, Qingyun et al. (2018) Predicting seizure by modeling synaptic plasticity based on EEG signals - a case study of inherited epilepsy. Commun Nonlinear Sci Numer Simul 56:330-343
Patni, Nivedita; Quittner, Claudia; Garg, Abhimanyu (2018) Orlistat Therapy for Children With Type 1 Hyperlipoproteinemia: A Randomized Clinical Trial. J Clin Endocrinol Metab 103:2403-2407

Showing the most recent 10 out of 520 publications